🇺🇸 FDA

Intelligence · Clinical Pipeline

Oncology · Phase I

Oncology programs at Phase I — ClinicalTrials.gov pipeline intelligence.

Programs
1,344

Quick answer

Oncology Phase I programs: NovaPharmaNews indexes 1,344 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 15 of 28

  1. GR-MD-02

    GALECTIN THERAPEUTICS INC

    Melanoma

    phase 1 small molecule completed

    1 trial

  2. GSK5533524

    GlaxoSmithKline

    Neoplasms

    phase 1 small molecule active

    1 trial

  3. GV20-0251

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HCC - Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  4. GX15-070MS

    Teva Pharma GmbH

    Chronic Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  5. GZ17-6.02

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Cancer

    phase 1 small molecule active

    1 trial

  6. Gallium-68 NODAGA-JR11

    The First People's Hospital of Lianyungang

    Neuroendocrine Tumors

    phase 1 small molecule active

    1 trial

  7. Gallium-68 citrate

    United Therapeutics Europe Ltd

    Prostatic Neoplasms

    phase 1 small molecule completed

    1 trial

  8. Gemtuzumab Ozogamicin

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  9. Gilteritinib

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia With FLT3/ITD Mutation

    phase 1 small molecule active

    1 trial

  10. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  11. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 1 mab active

    1 trial

  12. Guadecitabine

    United Therapeutics Europe Ltd

    Non Small Cell Lung Cancer

    phase 1 small molecule active

    1 trial

  13. HBT-708

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  14. HBV mRNA vaccine

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma (HCC)

    phase 1 mab active

    1 trial

  15. HBV mRNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    phase 1 mab active

    1 trial

  16. HEC68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Refractory Solid Tumors

    phase 1 small molecule completed

    1 trial

  17. HER-2/neu peptide vaccine

    Marker Therapeutics

    HER2-positive Breast Cancer

    phase 1 mab completed

    1 trial

  18. HER2 Tumor Vaccine

    The First People's Hospital of Lianyungang

    Adenocarcinoma - GEJ

    phase 1 mab active

    1 trial

  19. HER3-DXd

    Daiichi Sankyo

    Non-Small Cell Lung Cancer (NSCLC)

    phase 1 small molecule active

    1 trial

  20. HMPL-306

    Hutchison Medipharma Limited

    Acute Myeloid Leukemia

    phase 1 small molecule active

    1 trial

  21. HPV-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor

    phase 1 mab active

    1 trial

  22. HRS-2329 Tablet

    Jian Li

    Advanced Solid Tumors Harboring RAS Mutations or Amplifications

    phase 1 small molecule active

    1 trial

  23. HS-IT101 Injection

    Qingdao University

    Solid Tumor

    phase 1 small molecule active

    1 trial

  24. HTLP-onco-adult - A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies

    Pari Pharma GmbH

    hematologic malignancies ; acute myeloid leukemias

    phase 1 other active

    1 trial

  25. HW071021 Tablets

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  26. HW071021 Tablets

    Wuhan Humanwell Innovative Drug Research and Development Center Limited Company

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  27. HWK-007

    Whitehawk Therapeutics

    Endometrial Cancer

    phase 1 small molecule active

    1 trial

  28. HWS116 Injection

    BRIGHT MINDS BIOSCIENCES INC.

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  29. Health Promotion and Education

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking-Related Carcinoma

    phase 1 other completed

    1 trial

  30. Hema-NeoTIL01

    The First People's Hospital of Lianyungang

    Leukemia, Myeloid, Acute

    phase 1 mab active

    1 trial

  31. Hemay020

    Tianjin Hemay Pharmaceutical Co., Ltd

    Neoplasms，Non-Small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  32. Human Anti-PD-L1 Monoclonal Antibody Injection (LDP) Combined with Recombinant Anti-EGFR Human Mouse Chimeric Monoclonal Antibody Injection (CDP1)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Malignant Tumor

    phase 1 small molecule active

    1 trial

  33. I-131-CLR1404

    Cellectar Biosciences

    Cancer

    phase 1 small molecule completed

    1 trial

  34. I-131-CLR1404

    Cellectar Biosciences

    Solid Tumors

    phase 1 small molecule completed

    1 trial

  35. I124-NM404

    Cellectar Biosciences

    Non Small Cell Lung Cancer

    phase 1 small molecule completed

    1 trial

  36. IBR733 Cell Injection

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  37. ICG-Cisplatin Nanoprobe (NIR-II NanoM)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer, Adult

    phase 1 small molecule active

    1 trial

  38. ID-LV305

    Lxo Ireland Designated Activity Company

    Melanoma - Currently Enrolling

    phase 1 mab completed

    1 trial

  39. IDC-G305

    Lxo Ireland Designated Activity Company

    Melanoma

    phase 1 mab completed

    1 trial

  40. IDE-161

    IDEAYA Biosciences

    Advanced or Metastatic Solid Tumors

    phase 1 small molecule active

    1 trial

  41. IDE034

    IDEAYA Biosciences

    Esophageal Squamous Cell Carcinoma

    phase 1 small molecule active

    1 trial

  42. IDE397

    IDEAYA Biosciences

    Solid Tumor

    phase 1 small molecule active

    1 trial

  43. IDE892

    IDEAYA Biosciences

    NSCLC Adenocarcinoma

    phase 1 small molecule active

    1 trial

  44. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Cutaneous Melanoma, Stage III

    phase 1 mab completed

    1 trial

  45. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Cutaneous Squamous Cell Carcinoma

    phase 1 mab completed

    1 trial

  46. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Merkel Cell Carcinoma

    phase 1 mab completed

    1 trial

  47. IL-2

    Alaunos Therapeutics

    Lymphoma

    phase 1 small molecule completed

    1 trial

  48. IL-22BP mRNA vaccine injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Malignant Solid Tumors

    phase 1 mab active

    1 trial

Frequently asked questions

How many oncology Phase I programs exist?

1,344 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.